TC
XENT

TFS Capital’s Intersect ENT, Inc XENT Stock Holding History

TFS Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,657
Closed -$326K – 442
2017
Q2 		$326K Sell
11,657
-39,769
-77% -$900K 0.13% 318
2017
Q1 		$882K Buy
51,426
+22,024
+75% +$308K 0.29% 114
2016
Q4 		$356K Buy
+29,402
New +$381K 0.1% 368
2016
Q3 		– Sell
-94,674
Closed -$1.22M – 1062
2016
Q2 		$1.22M Buy
+94,674
New +$1.48M 0.23% 122
2015
Q4 		– Sell
-113,761
Closed -$2.66M – 967
2015
Q3 		$2.66M Buy
113,761
+70,393
+162% +$1.94M 0.26% 103
2015
Q2 		$1.24M Buy
43,368
+9,442
+28% +$247K 0.12% 277
2015
Q1 		$876K Buy
+33,926
New +$776K 0.09% 389

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TFS Capital's XENT Position: Q3 2017 in Review

TFS Capital sold out of Intersect ENT, Inc (XENT) in Q3 2017, closing a stake of 11,657 shares — an estimated $326K sold.

TFS Capital first reported a position in XENT in Q1 2015 and held it in 7 quarters. The position peaked at $2.66M in Q3 2015. 140 funds tracked by Wall St. Rank hold XENT as of Q3 2017.

  • TFS Capital reported no remaining Intersect ENT, Inc position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 11,657 Intersect ENT, Inc shares in Q3 2017, an estimated $326K.
  • TFS Capital first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 7 quarters.
  • TFS Capital's Intersect ENT, Inc position peaked at $2.66M in Q3 2015.
  • 140 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.